Mendus AB (publ) (STO:IMMU)
3.500
+0.070 (2.04%)
Nov 20, 2026, 5:29 PM CET
Mendus AB Market Cap
Mendus AB has a market cap or net worth of 217.29 million as of November 20, 2026. It is the 35,930th most valuable company in the world and the 494th biggest in Sweden. Its market cap has decreased by 19.19% in one year.
Market Cap
217.29M
Enterprise Value
179.47M
Revenue
n/a
Global Rank
Country Rank
#494 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2013, Mendus AB's market cap has increased from 117.09M to 217.29M, an increase of 85.58%. That is a compound annual growth rate of 4.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 217.29M | -36.63% |
| Dec 30, 2025 | 342.91M | -12.71% |
| Dec 30, 2024 | 392.86M | -12.97% |
| Dec 29, 2023 | 451.43M | -6.06% |
| Dec 30, 2022 | 480.56M | -43.76% |
| Dec 30, 2021 | 854.43M | -30.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 365.86M |
| Cantargia AB | 363.43M |
| Isofol Medical AB | 317.29M |
| Intervacc AB | 224.94M |
| Xbrane Biopharma AB | 213.27M |
| Initiator Pharma | 171.13M |
| Elicera Therapeutics AB | 164.51M |
| Abera Bioscience AB | 140.62M |